19/04/2015 15:12:00 Free Membership Login

Inovio Pharmaceuticals, Inc. News (NASDAQ:INO)

04/15/20158:59AMTMF3 Biotech Stocks That May Disappear Before 2020
http://www.fool.com/investing/general/2015/04/15/3-biotech-stocks-that-may-disappear-before-2020.aspx?source=eptadnlnk0000002 More...>>
04/09/20155:59PMSEEKWhy Investors Shouldn't Worry About Explosive New Drug Pricing: Maxim's Jason Kolbert
http://seekingalpha.com/article/3060866-why-investors-shouldnt-worry-about-explosive-new-drug-pricing-maxims-jason-kolbert?source=partner_advfn More...>>
04/09/201510:12AMGLOBEInovio Pharmaceuticals' HPV Immunotherapy Recognized as "Best Therapeutic Vaccine" by World Vaccine Congress
PLYMOUTH MEETING, Pa., April 9, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) today announced that it was recognized with a prestigious industry award at the World Vaccine Congress being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards honor outstanding vaccine advancements... More...>>
04/09/20159:11AMSEEKPremarket Gainers / Losers as of 9:10 am
http://seekingalpha.com/news/2417376-premarket-gainers-losers-as-of-9-10-am?source=partner_advfn More...>>
04/09/20158:00AMGLOBEInovio Pharmaceuticals HPV Immunotherapy Activates Robust In Vivo T Cell Responses in Head & Neck Cancer Patients
PLYMOUTH MEETING, Pa., April 9, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today preliminary data showing that its INO-3112 DNA-based immunotherapy generated strong CD8+ T cell responses in 3 of 4 patients with head and neck cancer associated with human papillomavirus (HPV) types... More...>>
04/08/20156:00AMGLOBEInovio Pharmaceuticals Selected by DARPA to Lead a $45 Million Program to Expedite Development of Novel Products to Prevent a...
PLYMOUTH MEETING, Pa., April 8, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that the company has been selected to receive a grant from the Defense Advanced Research Projects Agency (DARPA) to lead a collaborative team to develop multiple treatment and prevention approaches against... More...>>
04/04/20159:59AMTMFHas the Biotech Bubble Already Popped?
http://www.fool.com/investing/general/2015/04/04/has-the-biotech-bubble-already-popped.aspx?source=eptadnlnk0000002 More...>>
04/03/20158:04AMTMF5 Promising Biotech Stocks Under $10
http://www.fool.com/investing/small-cap/2015/04/03/5-promising-biotech-stocks-under-10.aspx?source=eptadnlnk0000002 More...>>
03/26/20156:01PMSEEK3 Biotechs That Could Change Medicine Forever: Wasatch Analyst Jill Wahleithner
http://seekingalpha.com/article/3032096-3-biotechs-that-could-change-medicine-forever-wasatch-analyst-jill-wahleithner?source=partner_advfn More...>>
03/19/20158:00AMGLOBEInovio Pharmaceuticals to Present at Alliance Regenerative Medicine's 2015 Regen Med Investor Day
PLYMOUTH MEETING, Pa., March 19, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that Chief Operating Officer, Dr. Niranjan Sardesai, will present at the 3rd Annual Regen Med Investor Day to be held Wednesday, March 25, 2015 at the Metropolitan Club in New York City. Dr. Sardesai's presentation... More...>>
03/18/20158:00AMGLOBEInovio Pharmaceuticals Appoints Scott M. White, M.D. Vice President, Clinical Development -- Infectious Diseases
PLYMOUTH MEETING, Pa., March 18, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today the appointment of Scott M. White, M.D. as Vice President, Clinical Development – Infectious Diseases. Dr. White will be responsible for advancing Inovio's infectious disease portfolio of DNA immunotherapies... More...>>
03/16/20152:10PMTMFWhy Inovio Pharmaceuticals Inc. Shot Higher Today
http://www.fool.com/investing/general/2015/03/16/why-inovio-pharmaceuticals-shot-higher-today.aspx?source=eptadnlnk0000002 More...>>
03/16/20158:00AMGLOBEInovio Pharmaceuticals and Academic Collaborators Receive $16 Million HIV Grant From National Institute of Allergy and Infect...
PLYMOUTH MEETING, Pa., March 16, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that the company and its academic collaborators, including the University of Pennsylvania (UPenn), were awarded a new five-year $16 million Integrated Preclinical/Clinical AIDS Vaccine Development Program... More...>>
03/16/20157:50AMSEEKInovio Pharma ups revenues 47% in Q4
http://seekingalpha.com/news/2369686-inovio-pharma-ups-revenues-47-percent-in-q4?source=partner_advfn More...>>
03/16/20156:43AMSEEKInovio Pharmaceuticals misses by $0.02, misses on revenue
http://seekingalpha.com/news/2369366-inovio-pharmaceuticals-misses-by-0_02-misses-on-revenue?source=partner_advfn More...>>
03/16/20156:30AMGLOBEInovio Pharmaceuticals Reports 2014 Fourth Quarter and Year End Financial Results
PLYMOUTH MEETING, Pa., March 16, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) today reported financial results for the fourth quarter and year ended December 31, 2014. Total revenue was $2.5 million and $10.5 million for the quarter and year ended December 31, 2014, as compared to $1.7 million and... More...>>
03/06/20158:30AMGLOBEInovio Pharmaceuticals to Report Fourth Quarter and Year End 2014 Financial Results on March 16, 2015
PLYMOUTH MEETING, Pa., March 6, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that it will host a conference call and live webcast to report its 2014 fourth quarter and year-end financial results on Monday, March 16, 2015 at 8:30 a.m. ET. A live and archived version of the audio presentation... More...>>
03/05/20158:46AMGLOBEInovio Pharmaceuticals Welcomes Nancy Wysenski to Its Board of Directors
PLYMOUTH MEETING, Pa., March 5, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO), a leader in the development of immunotherapies for cancer and infectious diseases, announced today that Nancy Wysenski joined its Board of Directors. Ms. Wysenski, a commercial pharmaceutical executive, has over 30 years... More...>>
02/03/201510:15AMBWU.S. Congressman Patrick Meehan to Present Keynote Address at 22nd Annual Groundhog Investment Forum
Congressman Meehan chaired the House Subcommittee on Cybersecurity in the 113th Congress and serves on the House Ways and Means Committee Emerald Asset Management, Inc. has announced that U.S. Congressman Patrick Meehan will present the keynote address to the close the 22nd annual Groundhog Day Investment Forum on Thursday... More...>>
02/02/20158:00AMGLOBEInovio Pharmaceuticals to Present at Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview at the 22nd Annual Emerald Groundhog Day Investment Forum on Thursday, February 5th at 2:45 PM ET. Hosted by Emerald Asset Management... More...>>

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us amex ino150419 15:12